2BB score and signals
Fulcrum Therapeutics, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 29 | Weak |
| Quality | 80 | Very Strong |
| Risk | 77 | High |
Fulcrum Therapeutics, Inc. (FULC) Stock Score & Signals
Fulcrum Therapeutics, Inc. (FULC) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 21 out of 100.
Company facts
| Founded | 2015 |
| Employees | 9 |
| 52-week range | $2.91 – $15.74 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-22 | — | -0.136 | — | $0.00 |
| 2026-10-29 | — | -0.1428 | — | $0.00 |
| 2026-08-05 | — | -0.2244 | — | $0.00 |
| 2026-04-27 | -0.25 | -0.3041 | — | $0.00 |